GENTALEK

This brand name is authorized in Nigeria.

Active ingredients

The drug GENTALEK contains one active pharmaceutical ingredient (API):

1	Gentamicin UNII 8X7386QRLV - GENTAMICIN SULFATE
	Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits.
	Read more about Gentamicin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-0220	Injection	Gentalek Injection 80mg/2ml INJ 80 mg 5 x 2ml x 10ampoules	37 RNW-PP-258436 Gentalek Injection 80mg/2ml GENTAMICIN Gentamicin (In form of Gentamicin Sulphate) - 80mg, Methylhydroxybenzoate - 1.6 mg, Propylhydroxybenzoate - 0.2 mg, Sodium metabisufite-1.6mg, Disodium edetate 0.2 mg, Propylene glycol 16.0 mg, Sulphuric acid or Sodium hydroxide for pH adjustment- q.s., Water for injections - A.d 2.0ml 04-0220 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Imported Products 5 x 2ml x 10ampoules Prescription Only Medicine (POM) 6/8/2022 NOVARTIS NIGERIA LIMITED, LANDMARK BUILDING 52/54 ISAAC JOHN STREET IKEJA-GRA LAGOS LAGOS 2.34707E+12 arit.onwusah@novartis.com LEK PHARMACEUTICALS, D.D. VEROVSKOVA 57, 1526, SLOVENIA , Slovenia	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01GB03	Gentamicin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01G Aminoglycoside antibacterials → J01GB Other aminoglycosides
Discover more medicines within J01GB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-0220